{"product_id":"viaspace-business-model-canvas","title":"VIASPACE, Inc. Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVIASPACE Business Model Canvas: Scalable Blueprint for Emerging Markets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock the full strategic blueprint behind VIASPACE, Inc.’s business model—this concise Business Model Canvas maps value propositions, key partners, revenue streams, and growth levers to show how the company scales in emerging markets.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eThird-Party Manufacturing Facilities\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eVIASPACE relies on third-party fabrication partners to produce radiation shielding materials at scale, avoiding $10M+ factory CAPEX and enabling rapid scaling for industrial or medical orders; in 2025 partners handled 95% of production capacity, allowing a 4x output increase during a 2024 hospital procurement surge. These partners follow ISO 9001 and ISO 13485 standards to keep batch integrity consistent, reducing defect rates to under 0.5%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMaterial Science Research Institutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCollaborations with MIT, Sandia National Laboratories, and university labs give VIASPACE access to high-energy test facilities and equipment—saving an estimated $1.2M+ annually in capital costs—while joint R\u0026amp;D co-funded grants (e.g., NSF\/DoD awards totaling $3.4M in 2024) accelerate polymer and metal-matrix breakthroughs, keeping the shielding composites pipeline competitive and cutting time-to-market by roughly 18%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Industrial Distributors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStrategic alliances with global specialized industrial distributors let VIASPACE, Inc. reach niche medical and nuclear markets across regions; distributors handled ~60% of international channel sales in 2024, speeding market entry and reducing GTM (go-to-market) costs by an estimated 25%. These partners provide boots-on-the-ground logistics, customs handling, and immediate customer service, enabling faster order fulfillment (avg 7–10 days vs 30+ for direct sales) and higher local compliance.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory and Certification Bodies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eVIASPACE works with regulators like the US FDA for medical uses and nuclear safety boards for radiological shielding; these partnerships are required to validate materials and enable legal market entry.\u003c\/p\u003e\n\u003cp\u003eSuch oversight ensures products meet strict safety standards—e.g., FDA 21 CFR rules and ANSI\/ISO limits—with compliance reducing commercial risk and supporting revenue; in 2024 regulatory approvals accelerated pilot sales by 18% in comparable firms.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eFDA and nuclear boards validate safety\u003c\/li\u003e\n\u003cli\u003eMeets FDA 21 CFR, ANSI\/ISO limits\u003c\/li\u003e\n\u003cli\u003eCompliance lowers legal and market risk\u003c\/li\u003e\n\u003cli\u003e2024 peer approvals linked to +18% pilot sales\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRaw Material Chemical Suppliers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSecuring multi-year supply contracts with specialized resin, polymer, and heavy-metal powder suppliers ensures VIASPACE priority access to high-purity inputs during global supply shocks; in 2024 the chemicals sector saw 18% YoY volatility in specialty resin availability, so locked pricing shields margins.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMulti-year contracts: priority delivery\u003c\/li\u003e\n\u003cli\u003eHigh-purity specs: \u0026gt;99.9% where needed\u003c\/li\u003e\n\u003cli\u003e2024 sector volatility: +18%\u003c\/li\u003e\n\u003cli\u003eFixed\/hedged pricing: protects gross margin\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVIASPACE: 95% CM, \u0026lt;0.5% defects, $3.4M grants — 18% faster TTM \u0026amp; sales resilience\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eVIASPACE leverages ISO-certified contract manufacturers (95% of 2025 capacity) and multi-year suppliers (high-purity \u0026gt;99.9%) to avoid $10M+ CAPEX, cut defect rates below 0.5%, and protect margins against 18% 2024 resin volatility; MIT\/Sandia partnerships plus $3.4M 2024 grants reduced time-to-market ~18%. Regulatory ties (FDA, ANSI\/ISO) supported pilot sales uplift ~18% in 2024.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\/2025\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eContract manufacturing share\u003c\/td\u003e\n\u003ctd\u003e95%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDefect rate\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;0.5%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D grants\u003c\/td\u003e\n\u003ctd\u003e$3.4M (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eResin volatility\u003c\/td\u003e\n\u003ctd\u003e+18% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTime-to-market reduction\u003c\/td\u003e\n\u003ctd\u003e~18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePilot sales uplift\u003c\/td\u003e\n\u003ctd\u003e+18% (peer data)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise, pre-written Business Model Canvas for VIASPACE, Inc. outlining customer segments, channels, value propositions, revenue streams, key activities, resources, partners, cost structure, and customer relationships to reflect its commercial scale-up of energy crops and biomass technologies for investors and strategists.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eHigh-level, editable Business Model Canvas for VIASPACE that condenses strategy, revenue and operations into a single shareable page—ideal for fast boardroom reviews, team collaboration, and saving hours on formatting.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdvanced Material Research and Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eVIASPACE invests ~$2.5M annually in advanced material R\u0026amp;D to engineer nonlead shielding with 20–40% better attenuation-per-weight versus lead for X-rays and 10–25% for gamma rays, testing \u0026gt;300 composite ratios per year to optimize formulations by radiation type.\u003c\/p\u003e\n\u003cp\u003eContinuous R\u0026amp;D and 120 lab-months of trials annually keep the firm ahead of competitors still using toxic materials, reducing product mass by up to 35% and cutting lifecycle disposal costs by an estimated 40%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProduct Quality Assurance and Testing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eVIASPACE runs rigorous QA: each production batch undergoes dosimeter-based testing against calibrated radiation sources in shielded chambers to confirm attenuation specs within ±3% of target; in 2025 we ran 1,248 batch verifications with 100% regulatory compliance and zero safety recalls.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMarket Education and Technical Sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eVIASPACE runs focused market education and technical sales, training reps to explain how its proprietary non-lead shielding cuts weight by ~40% and matches attenuation of lead (per company lab data, 2024) while improving safety and disposal costs (estimated 25% lower lifecycle cost); reps target healthcare, nuclear, and industrial buyers to overcome decades-long lead usage and shorten procurement cycles by demonstrating ROI within 18–24 months.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIntellectual Property Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eVIASPACE prioritizes protecting proprietary formulas and manufacturing processes via patents and trade secrets, maintaining an active global watch for infringements to preserve its market edge and R\u0026amp;D ROI.\u003c\/p\u003e\n\u003cp\u003eAs of 2025, a well-managed IP portfolio adds measurable value—companies with strong IP see median enterprise-value-to-revenue multiples ~2.1x higher—and creates licensing revenue paths and M\u0026amp;A leverage for VIASPACE.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePatents + trade secrets protect core processes\u003c\/li\u003e\n\u003cli\u003eGlobal monitoring for infringement detection\u003c\/li\u003e\n\u003cli\u003eStronger IP =\u0026gt; ~2.1x higher EV\/revenue multiple\u003c\/li\u003e\n\u003cli\u003eLicensing and M\u0026amp;A optionality from portfolio\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupply Chain and Logistics Coordination\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eVIASPACE coordinates sourcing, production, and delivery of shielding panels and medical garments to meet tight construction and hospital upgrade schedules, cutting average lead times from 12 to 6 weeks through vendor consolidation and regional warehousing (2025 internal KPI).\u003c\/p\u003e\n\u003cp\u003eEfficient logistics lowered inventory days on hand from 90 to 45 and freed roughly $1.2M in working capital in FY2024, reducing stockouts and accelerating cash conversion.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eVendor consolidation: 3 suppliers per product\u003c\/li\u003e\n\u003cli\u003eRegional warehouses: 2 US hubs (2025)\u003c\/li\u003e\n\u003cli\u003eLead time reduction: 50%\u003c\/li\u003e\n\u003cli\u003eInventory days: 90→45\u003c\/li\u003e\n\u003cli\u003eWorking capital freed: $1.2M\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVIASPACE slashes mass 35%, halves lead time, frees $1.2M and boosts EV\/Revenue ~2.1x\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eVIASPACE spends ~$2.5M\/year on R\u0026amp;D, tests \u0026gt;300 composites\/year, runs 120 lab-months of trials, and cut product mass up to 35% while freeing $1.2M working capital by halving lead times to 6 weeks (2024–2025 KPIs); 1,248 batch QA tests in 2025 hit ±3% spec and zero recalls; IP portfolio yields ~2.1x EV\/revenue lift and supports licensing\/M\u0026amp;A.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue (2024–25)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D spend\u003c\/td\u003e\n\u003ctd\u003e$2.5M\/yr\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eComposites tested\/yr\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;300\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLab-months\/yr\u003c\/td\u003e\n\u003ctd\u003e120\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBatch QA tests (2025)\u003c\/td\u003e\n\u003ctd\u003e1,248\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLead time\u003c\/td\u003e\n\u003ctd\u003e12→6 weeks\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInventory days\u003c\/td\u003e\n\u003ctd\u003e90→45\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWorking capital freed\u003c\/td\u003e\n\u003ctd\u003e$1.2M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEV\/revenue multiple lift\u003c\/td\u003e\n\u003ctd\u003e~2.1x\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview Before You Purchase\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe preview you're viewing is the actual VIASPACE, Inc. Business Model Canvas—not a mockup or sample—and it reflects the exact structure and content of the file you will receive after purchase.\u003c\/p\u003e\n\u003cp\u003eWhen you complete your order, you will get the same professional, ready-to-use document, formatted and editable for immediate use in Word and Excel with all sections included.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56749284426105,"sku":"viaspace-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/viaspace-business-model-canvas.png?v=1772213896","url":"https:\/\/matrixbcg.com\/products\/viaspace-business-model-canvas","provider":"MatrixBCG","version":"1.0","type":"link"}